Is a complete PLSE research report available?

No complete published report is available for Pulse Biosciences, Inc. (PLSE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · USD

$30.2

-0.77 (-2.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PLSE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.1B
Revenue (ttm)	751K
Net income (ttm)	-74.6M
EPS (ttm)	-$1.10
Shares out	69.2M
Volume	367,455
Beta	1.65
Price target	$30.7	+1.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 751K
Net income (ttm): -74.6M
EPS (ttm): -$1.10
Market cap: 2.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PLSE indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001625101
Company name	Pulse Biosciences, Inc.
Country	United States
Country code	US
Cusip	74587B101
Employees	116
Employees Change	41%
Employees Change Percent	54.67
Enterprise value	$2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.74
Industry PE Fwd	20.56
IPO Date	2016-05-18
Isin	US74587B1017
Last refreshed	2026-07-25
Market cap	$2.1B
Market cap category	Mid-Cap
Price	$30.23
Price currency	USD
Rev Per Employee	6,474.14x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	3841
Symbol	PLSE
Website	https://www.pulsebiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.56%
EV Sales Forward	591.57x
EV/Sales	2,704.45x
FCF yield	-2.65%
P/B ratio	31.11x
P/S ratio	2,785.9x
PS Forward	609.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10,392.14%
EBITDA Margin	-10,253.26%
Gross margin	-21.04%
Gross Profit	$-158,000
Net Income	$-74.6M
Net Income Growth Years	0%
Pretax Margin	-9,929.03%
Profit Per Employee	$-642,819
ROA	-45.03
Roa5y	-51.24
ROCE	-108.7
ROE	-80.72
Roe5y	-181.9
ROIC	-48.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.99%
Cagr1y	99.37%
Cagr3y	65.64%
Cagr5y	8.55%
EPS Growth Years	0
Revenue Growth Years	0x
Revenue Growth3 Y	43.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$81.6M
Cash	$68.3M
Current Assets	$71.1M
Current Liabilities	$9.8M
Debt	$7.2M
Debt Equity	$0.11
Equity	$66.3M
Liabilities	$15.3M
Long Term Assets	$10.5M
Long Term Liabilities	$5.5M
Net Cash	$61.2M
Net Cash By Market Cap	$2.92
Net Cash Growth	-44.75%
Net Debt Equity	$-0.92
Tangible Book Value	$63.1M
Tangible Book Value Per Share	$0.92
WACC	13.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.26
Inventory Turnover	7.7
Net Working Capital	$-5.4M
Quick ratio	6.99
Working Capital	$61.3M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.03%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	571.78%
1Y total return	99.28%
200-day SMA	19.97
3Y total return	354.59%
50-day SMA	26.66
50-day SMA vs 200-day SMA	50over200
5Y total return	50.7%
All Time High	45.82
All Time High Change	-34.02%
All Time High Date	2021-02-08
All Time Low	1.18
All Time Low Change	2,461.86%
All Time Low Date	2022-08-30
ATR	2.02
Beta	1.65
Beta1y	0.46
Beta2y	1.28
Ch YTD	120.2
High	31.39
High52	33.87
High52 Date	2026-07-22
High52ch	-10.75%
Low	29.51
Low52	12.56
Low52 Date	2025-11-20
Low52ch	140.69%
Ma50ch	13.41%
Price vs 200-day SMA	51.39%
RSI	58.86
RSI Monthly	72.89
RSI Weekly	65.34
Sharpe ratio	1.14x
Sortino ratio	2.36
Total Return	-11.03%
Tr YTD	120.2
Tr1m	16.49%
Tr1w	5.4%
Tr3m	24.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$30
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.29
Earnings Revenue Estimate	566,664x
Operating Income	$-77.4M
Operating margin	-10,312.3
Price target	$30.67
Price Target Change	$1.46
Price Target Change Top	$-0.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,477,077%
Float Percent	26.7%
Shares Insiders	72.39%
Shares Institutions	11.45%
Shares Out	69,209,712
Shares Qo Q	0.3%
Shares Yo Y	11.03%
Short Float	15.46%
Short Ratio	7.5
Short Shares	4.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-73.2M
Average Volume	377,635.7x
Bv Per Share	0.97
CAPEX	$-303,000
Ch10y	571.8
Ch1m	16.49
Ch1w	5.4
Ch1y	99.28
Ch3m	24.66
Ch3y	354.6
Ch5y	50.7
Ch6m	100.3
Change	-2.48%
Change From Open	-2.61
Close	31
Days Gap	0.13
Depreciation Amortization	1,043,000
Dollar Volume	11,108,164.7
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-78M
EBITDA	$-77M
EPS	$-1.1
F Score	1
FCF	$-55.5M
FCF EV Yield	-2.73x
FCF Per Share	$-0.8
Financing CF	4,559,000
Fiscal Year End	December
Founded	2,014
Goodwill	2,791,000
Investing CF	-323,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	21.45
Ma150ch	40.97%
Ma20	28.43
Ma20ch	6.32%
Net CF	-50,960,000
Next Earnings Date	2026-08-06
Open	31.04
Optionable	Yes
Position In Range	38.3
Post Close	30.23
Postmarket Change Percent	0.07
Postmarket Price	$30.25
Ppne	6,718,000
Price Date	2026-07-24
Ptbv Ratio	33.16
Relative Volume	0.97x
Revenue	751,000x
SBC By Revenue	2,355.26x
Share Based Comp	17,688,000
Tr6m	100.33%
Us State	Florida
Volume	367,455
Z Score	33.38

Pulse Biosciences, Inc. (PLSE)

Coverage state: Market snapshot only — no published research

Generate the first PLSE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PLSE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PLSE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PLSE

Frequently asked questions